세계의 순환종양세포 시장 보고서(2023년)

“Circulating Tumor Cells Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on circulating tumor cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for circulating tumor cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The circulating tumor cells market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Kits And Reagents; Blood Collection Tubes; Devices Or Systems

• 2) By Technology: CTC Enrichment; CTC Detection; CTC Analysis

• 3) By Specimen: Blood; Bone Marrow; Other Body Fluids

• 4) By Application: Clinical Or Liquid Biopsy; Research

• Companies Mentioned: Precision Medicine Group LLC; Bio-Techne Corporation; BIOCEPT Inc.; Creativ MicroTech Inc.; Fluxion Biosciences Inc.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the circulating tumor cells market are Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec, Menarini Silicon Biosystems, Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, and LineaRx Inc.

The global circulating tumor cells market is expected to grow from $9.52 billion in 2022 to $10.71 billion in 2023 at a compound annual growth rate (CAGR) of 12.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The circulating tumor cells market is expected to grow to $16.70 billion in 2027 at a CAGR of 11.7%.

The circulating tumor cells market consists of sales of clinical samples, KRT7, PSMA positive cells, and TTF-1 positive. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Circulating tumor cells refer to solid tumor-derived cells that have shed from the primary tumor and are extravasated into the blood circulation system. They are used as a tool to diagnose and prognosis of cancer.

North America was the largest region in the circulating tumor cells market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main products of circulating tumor cells include kits and reagents, blood collection tubes and devices or systems. Kits and reagents are a complete set of consumables that include a blood specimen separator, proprietary microfluidic capture chip, CTC enrichment, and immunostaining reagents. They are collected using different specimens of a human body including blood, bone marrow and other body fluids by using different technologies such as CTC enrichment, CTC detection and CTC analysis that are used for clinical or liquid biopsy and research applications.

The growing incidence of cancer is expected to propel the circulating tumor cells market growth going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. Circulating tumor cells are used to help in the early detection and diagnosis of cancer, and thus growing incidence of cancer propels the growth of the circulating tumor cells market. For instance, in 2020, according to the World Health Organization (WHO), a Switzerland-based international agency responsible for international public health, in 2020, there were around 19.29 million new cancer cases, and the number of cancer cases in 5 years span is estimated to be 50.55 million. Therefore, the growing incidence of cancer is driving the growth of the circulating tumor cells market.

Product innovations are a key trend gaining popularity in the circulating tumor cells market. Major companies operating in the circulating tumor cells market are focused on developing innovative products to strengthen their position in the market. For instance, in February 2021, Menarini Silicon Biosystems, an Italy-based company operating in liquid biopsy and single-cell technologies, launched the new CellMag CTC Epithelial Cell kit. The kit uses ferrofluid technology to streamline the manual immuno-magnetic enrichment and staining of rare CTCs (circulating tumor cells). It is a cost-effective and simple protocol for liquid biopsy labs by allowing standardization of sample preparation.

In April 2021, Agilent Technologies Inc., a US-based provider of software, instruments, and services for laboratory workflow, acquired Resolution Bioscience Inc. for an undisclosed amount. Through this acquisition, Agilent expands and strengthens its capabilities in cancer diagnostics and provides innovative technology to serve the medicine market. Resolution Bioscience, Inc. is a US-based developer of next-generation sequencing-based oncology solutions.

The countries covered in the circulating tumor cells market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The circulating tumor cells market research report is one of a series of new reports from The Business Research Company that provides circulating tumor cells market statistics, including circulating tumor cells industry global market size, regional shares, competitors with a circulating tumor cells market share, detailed circulating tumor cells market segments, market trends and opportunities, and any further data you may need to thrive in the circulating tumor cells industry. This circulating tumor cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Circulating Tumor Cells Market Characteristics

3. Circulating Tumor Cells Market Trends And Strategies

4. Circulating Tumor Cells Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Circulating Tumor Cells Market
• 4.2. Ukraine-Russia War Impact On Circulating Tumor Cells Market
• 4.3. Impact Of High Inflation On Circulating Tumor Cells Market

5. Circulating Tumor Cells Market Size And Growth

• 5.1. Global Circulating Tumor Cells Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Circulating Tumor Cells Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Circulating Tumor Cells Market Segmentation

• 6.1. Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Kits And Reagents
• Blood Collection Tubes
• Devices Or Systems
• 6.2. Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• CTC Enrichment
• CTC Detection
• CTC Analysis
• 6.3. Global Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Blood
• Bone Marrow
• Other Body Fluids
• 6.4. Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Clinical Or Liquid Biopsy
• Research

7. Circulating Tumor Cells Market Regional And Country Analysis

• 7.1. Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Circulating Tumor Cells Market

• 8.1. Asia-Pacific Circulating Tumor Cells Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Circulating Tumor Cells Market

• 9.1. China Circulating Tumor Cells Market Overview
• 9.2. China Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Circulating Tumor Cells Market

• 10.1. India Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Circulating Tumor Cells Market

• 11.1. Japan Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Circulating Tumor Cells Market

• 12.1. Australia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Circulating Tumor Cells Market

• 13.1. Indonesia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Circulating Tumor Cells Market

• 14.1. South Korea Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Circulating Tumor Cells Market

• 15.1. Western Europe Circulating Tumor Cells Market Overview
• 15.2. Western Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Circulating Tumor Cells Market

• 16.1. UK Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Circulating Tumor Cells Market

• 17.1. Germany Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Circulating Tumor Cells Market

• 18.1. France Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Circulating Tumor Cells Market

• 19.1. Eastern Europe Circulating Tumor Cells Market Overview
• 19.2. Eastern Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Circulating Tumor Cells Market

• 20.1. Russia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Circulating Tumor Cells Market

• 21.1. North America Circulating Tumor Cells Market Overview
• 21.2. North America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Circulating Tumor Cells Market

• 22.1. USA Circulating Tumor Cells Market Overview
• 22.2. USA Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Circulating Tumor Cells Market

• 23.1. South America Circulating Tumor Cells Market Overview
• 23.2. South America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Circulating Tumor Cells Market

• 24.1. Brazil Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Circulating Tumor Cells Market

• 25.1. Middle East Circulating Tumor Cells Market Overview
• 25.2. Middle East Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Circulating Tumor Cells Market

• 26.1. Africa Circulating Tumor Cells Market Overview
• 26.2. Africa Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Circulating Tumor Cells Market Competitive Landscape And Company Profiles

• 27.1. Circulating Tumor Cells Market Competitive Landscape
• 27.2. Circulating Tumor Cells Market Company Profiles
  • 27.2.1. Precision Medicine Group LLC
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Bio-Techne Corporation
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. BIOCEPT Inc.
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Creativ MicroTech Inc.
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Fluxion Biosciences Inc.
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Circulating Tumor Cells Market

29. Circulating Tumor Cells Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer